Xiaoping Liu

713 total citations
29 papers, 582 citations indexed

About

Xiaoping Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaoping Liu has authored 29 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Xiaoping Liu's work include Drug Transport and Resistance Mechanisms (5 papers), Metal complexes synthesis and properties (4 papers) and Pregnancy and preeclampsia studies (3 papers). Xiaoping Liu is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Metal complexes synthesis and properties (4 papers) and Pregnancy and preeclampsia studies (3 papers). Xiaoping Liu collaborates with scholars based in China, United States and Hong Kong. Xiaoping Liu's co-authors include Xiaoming Xie, Lu Yang, Hailin Tang, Cailu Song, Ning Li, Feng Ye, Xinhua Xie, Yanan Kong, Neng Wang and Jianping Chen and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Stem Cells.

In The Last Decade

Xiaoping Liu

28 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Liu China 13 308 244 144 79 53 29 582
Sandeep Batra United States 10 274 0.9× 134 0.5× 80 0.6× 88 1.1× 23 0.4× 38 689
Sayed S. Daoud United States 17 459 1.5× 294 1.2× 94 0.7× 37 0.5× 45 0.8× 38 771
Miranda L. Lynch United States 12 347 1.1× 149 0.6× 215 1.5× 92 1.2× 23 0.4× 28 728
T C Hamilton United States 10 431 1.4× 314 1.3× 122 0.8× 46 0.6× 41 0.8× 14 781
Yue-Li Sun China 10 248 0.8× 230 0.9× 70 0.5× 42 0.5× 40 0.8× 23 535
J. Rebecca Liu United States 14 321 1.0× 149 0.6× 132 0.9× 42 0.5× 26 0.5× 18 555
Janet S. Macpherson United Kingdom 16 385 1.3× 333 1.4× 65 0.5× 69 0.9× 98 1.8× 30 861
Ayşe Latif United Kingdom 14 227 0.7× 153 0.6× 141 1.0× 40 0.5× 19 0.4× 26 645
Karobi Moitra United States 14 411 1.3× 451 1.8× 151 1.0× 42 0.5× 79 1.5× 20 791

Countries citing papers authored by Xiaoping Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Liu more than expected).

Fields of papers citing papers by Xiaoping Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Liu. The network helps show where Xiaoping Liu may publish in the future.

Co-authorship network of co-authors of Xiaoping Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Liu. A scholar is included among the top collaborators of Xiaoping Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Liu. Xiaoping Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Hang, Yang Xu, Xiaoping Liu, et al.. (2022). From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer. Frontiers in Oncology. 11. 819565–819565. 7 indexed citations
2.
Tao, Hui, Xiaoping Liu, Xiaoxia Liu, et al.. (2019). LncRNA MEG3 inhibits trophoblast invasion and trophoblast‐mediated VSMC loss in uterine spiral artery remodeling. Molecular Reproduction and Development. 86(6). 686–695. 33 indexed citations
3.
4.
5.
Zhang, Chao, et al.. (2018). Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line. Molecular Medicine Reports. 18(6). 5409–5416. 28 indexed citations
6.
Liu, Xiaoping, et al.. (2017). Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Biochemical and Biophysical Research Communications. 490(3). 1112–1118. 20 indexed citations
7.
Liu, Xiaoxia, Qingqing Luo, Yanfang Zheng, et al.. (2016). NOTCH4 signaling controls EFNB2-induced endothelial progenitor cell dysfunction in preeclampsia. Reproduction. 152(1). 47–55. 12 indexed citations
8.
Kong, Jing, Xiaoping Liu, Xiangqian Li, et al.. (2016). Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription. Hepatology International. 10(3). 493–500. 20 indexed citations
9.
Deng, Changchun, Luigi Scotto, Shirong Li, et al.. (2016). Silencing c-Myc Translation As a Therapeutic Strategy through Targeting PI3K Delta and CK1 Epsilon in Hematological Malignancies. Blood. 128(22). 291–291. 7 indexed citations
10.
Wang, Ji, Yi Li, Hongbing Ma, et al.. (2015). Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells. BioMed Research International. 2015. 1–12. 22 indexed citations
11.
Liu, Xiangfeng, Xiongying Miao, Xiaoping Liu, et al.. (2014). Laparoscopic Left Hemihepatectomy for Treatment of Left Intrahepatic Duct Stones. The American Surgeon. 80(12). 350–351. 5 indexed citations
12.
Lin, Xiaoti, Minqing Wu, Peng Liu, et al.. (2014). Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer. Medical Oncology. 31(4). 868–868. 11 indexed citations
13.
Lin, Zewei, Yong Xie, Xiaoping Liu, et al.. (2014). The Expression Levels of Transcription Factors T-bet, GATA-3, RORγt and FOXP3 in Peripheral Blood Lymphocyte (PBL) of Patients with Liver Cancer and their Significance. International Journal of Medical Sciences. 12(1). 7–16. 31 indexed citations
14.
Zheng, Ying, Wenling Zhang, Qiurong Ye, et al.. (2012). Inhibition of Epstein-Barr Virus Infection by Lactoferrin. Journal of Innate Immunity. 4(4). 387–398. 33 indexed citations
15.
Zhou, Dong‐Dong, Lin-Liang Yu, Song Han, et al.. (2012). Syntheses, Crystal Structures and Antibacterial Properties of Bis(1-benzyl-4′-R-pyridinium)tetrabromocuprate(II) [R = NH2 or N(CH3)2]. Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 42(2). 238–245. 7 indexed citations
16.
Ren, Juan, Zi Liu, Xiaoping Liu, et al.. (2011). Primary myoepithelial carcinoma of palate. World Journal of Surgical Oncology. 9(1). 104–104. 26 indexed citations
17.
Zhou, Dong‐Dong, et al.. (2011). Two Tetrachlorocuprate(II) Salts with Substituted Benzyl Pyridinium: Syntheses, Crystal Structures, and Antibacterial Properties. Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry. 41(5). 525–530. 8 indexed citations
18.
Rosenberg, Mark F., Zsolt Bikádi, Xiaoping Liu, et al.. (2010). The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone. Structure. 18(12). 1688–1689. 3 indexed citations
19.
Rosenberg, Mark F., Zsolt Bikádi, Xiaoping Liu, et al.. (2010). The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone. Structure. 18(4). 482–493. 71 indexed citations
20.
Liu, Xiaoping, et al.. (2009). The tissue distribution in mice and pharmacokinetics in rabbits of oxaliplatin liposome. Journal of Liposome Research. 19(4). 278–286. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandeep Batra Breakdown of academic impact, for papers by Sayed S. Daoud Breakdown of academic impact, for papers by Miranda L. Lynch Breakdown of academic impact, for papers by T C Hamilton Breakdown of academic impact, for papers by Yue-Li Sun Breakdown of academic impact, for papers by J. Rebecca Liu Breakdown of academic impact, for papers by Janet S. Macpherson Breakdown of academic impact, for papers by Ayşe Latif Breakdown of academic impact, for papers by Karobi Moitra
Rankless by CCL
2026